![]() |
Volumn 13, Issue 6, 2011, Pages 631-634
|
Should cystic fibrosis patients infected with Burkholderia cepacia complex be listed for lung transplantation?
|
Author keywords
Bacterial infection; Burkholderia cenocepacia; Burkholderia cepacia complex; Cystic fibrosis; Lung transplantation; Transplantation outcome
|
Indexed keywords
ANTIINFECTIVE AGENT;
ARTICLE;
BACTERIAL COLONIZATION;
BACTERIUM IDENTIFICATION;
BURKHOLDERIA CENOCEPACIA;
BURKHOLDERIA CENOCEPACIA INFECTION;
BURKHOLDERIA CEPACIA;
BURKHOLDERIA CEPACIA COMPLEX;
BURKHOLDERIA INFECTION;
CYSTIC FIBROSIS;
GRAFT SURVIVAL;
HEALTH CARE ACCESS;
HUMAN;
LUNG TRANSPLANTATION;
MORTALITY;
NONHUMAN;
PATIENT ASSESSMENT;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
RISK ASSESSMENT;
SURVIVAL TIME;
SYSTEMATIC REVIEW;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
BENCHMARKING;
BURKHOLDERIA CEPACIA COMPLEX;
BURKHOLDERIA INFECTIONS;
CYSTIC FIBROSIS;
EVIDENCE-BASED MEDICINE;
FEMALE;
HUMANS;
LUNG TRANSPLANTATION;
MALE;
PATIENT SELECTION;
RISK ASSESSMENT;
RISK FACTORS;
TIME FACTORS;
TREATMENT OUTCOME;
WAITING LISTS;
YOUNG ADULT;
|
EID: 83255170874
PISSN: 15699293
EISSN: 15699285
Source Type: Journal
DOI: 10.1510/icvts.2011.271874 Document Type: Article |
Times cited : (24)
|
References (8)
|